3 completed. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 3 |
Follow Diagnostic Imaging: new trials by email Literature Review of Diagnostic Imaging trials Research Report on Diagnostic Imaging
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Gadobutrol 1.0 Molar (Gadovist) for Breast MRI Gadobutrol (Gadavist, Gadovist, BAY86-4875) - Breast Cancer, Diagnostic Imaging | Phase 3 | Completed | Bayer | 446 | 2010-02-01 | 2014-11-11 |
| Safety and Efficacy of Gadobutrol 1.0 Molar (Gadavist) in Patients for Central Nervous System (CNS) Imaging Gadobutrol (Gadavist, Gadovist, BAY86-4875), Gadoteridol (ProHance) - Diagnostic Imaging, Central Nervous System Diseases | Phase 3 | Completed | Bayer | 402 | 2008-06-01 | 2014-12-30 |
| Ultravist: Safety and Efficacy in Computed Tomography of Head and Body Iopromide 370 mg I/mL, Iopromide 300 mg I/mL - Computed Tomography, Diagnostic Imaging | Phase 3 | Completed | Bayer | 435 | 2005-10-01 | 2014-02-28 |
Breast Neoplasms (1) · Central Nervous System Diseases (1)
Breast Diseases (1) · Neoplasms (1) · Neoplasms by Site (1) · Nervous System Diseases (1) · Skin Diseases (1) · Skin and Connective Tissue Diseases (1)
gadobutrol (2) · gadoteridol (1) · iopromide (1)
Bayer (3)
Colombia (3) · United States (3) · Germany (2) · India (2) · South Korea (2) · Switzerland (2) · Argentina (1) · Australia (1) · Austria (1) · Brazil (1) · Finland (1) · Italy (1) · Japan (1)
2009 (1)